These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Dose-response of n-3 polyunsaturated fatty acids on lipid profile and tolerability in mildly hypertriglyceridemic subjects. Park Y; Harris WS J Med Food; 2009 Aug; 12(4):803-8. PubMed ID: 19735180 [TBL] [Abstract][Full Text] [Related]
28. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. Maki KC; McKenney JM; Reeves MS; Lubin BC; Dicklin MR Am J Cardiol; 2008 Aug; 102(4):429-33. PubMed ID: 18678300 [TBL] [Abstract][Full Text] [Related]
29. [Medium- and long-chain fatty acid triacylglycerol reduce body fat and serum triglyceride in overweight and hypertriglyceridemic subjects]. Zhang YH; Liu YH; Zheng ZX; Wang J; Zhang Y; Zhang RX; Yu XM; Jing HJ; Xue CY; Wu J Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep; 43(9):765-71. PubMed ID: 20137557 [TBL] [Abstract][Full Text] [Related]
30. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375 [TBL] [Abstract][Full Text] [Related]
31. Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects. Asakura L; Lottenberg AM; Neves MQ; Nunes VS; Rocha JC; Passarelli M; Nakandakare ER; Quintão EC Am J Clin Nutr; 2000 Mar; 71(3):701-5. PubMed ID: 10702162 [TBL] [Abstract][Full Text] [Related]
33. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782 [TBL] [Abstract][Full Text] [Related]
34. Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial. Tremblay BL; Cormier H; Rudkowska I; Lemieux S; Couture P; Vohl MC Lipids Health Dis; 2015 Feb; 14():12. PubMed ID: 25889305 [TBL] [Abstract][Full Text] [Related]
35. Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia. Oh PC; Koh KK; Sakuma I; Lim S; Lee Y; Lee S; Lee K; Han SH; Shin EK Int J Cardiol; 2014 Oct; 176(3):696-702. PubMed ID: 25147070 [TBL] [Abstract][Full Text] [Related]
36. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Skulas-Ray AC; Kris-Etherton PM; Harris WS; Vanden Heuvel JP; Wagner PR; West SG Am J Clin Nutr; 2011 Feb; 93(2):243-52. PubMed ID: 21159789 [TBL] [Abstract][Full Text] [Related]
39. The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: Reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects. Ahn HY; Kim M; Ahn YT; Sim JH; Choi ID; Lee SH; Lee JH Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):724-33. PubMed ID: 26044516 [TBL] [Abstract][Full Text] [Related]
40. Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia. Paranandi A; Asztalos BF; Mangili A; Kuvin J; Gerrior J; Sheehan H; Skinner SC; Tang AM; Wanke CA AIDS Res Hum Retroviruses; 2014 Aug; 30(8):800-5. PubMed ID: 24988179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]